DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD25 ADC
The present disclosure relates to novel dosage regimes for the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to novel dosage regimes for the administration of ADCs which bind to CD25 (CD25-ADCS). La présente...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure relates to novel dosage regimes for the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to novel dosage regimes for the administration of ADCs which bind to CD25 (CD25-ADCS).
La présente invention concerne de nouveaux régimes posologiques pour le traitement d'états pathologiques, tels que le cancer, avec des Conjugués Anticorps-Médicaments (CAM). En particulier, la présente invention concerne de nouveaux régimes posologiques pour l'administration de CAM qui se lient à CD25 (CAM-CD25). |
---|